A past study reported the association of SIGLEC10 in impeding NK cell function and poor patient survival in hepatocellular carcinoma (HCC); CD24/SIGLEC10 interaction may thus be involved in regulating NK cell function53. Here, SIGLEC10 is linked to hepatocellular carcinoma.